Company intelligence / Profile preview
Rui Therapeutics
Guangdong Sheng, Chinaruitherapeutics.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Rui Therapeutics has reported the world's first clinical trial data for CAR-NK treatment of lupus, showing deep remission in severe SLE patients after infusion of their universal/off-the-shelf CAR-NK product KN5501. Early IIT trials have demonstrated excellent safety and tumor cell clearance effects for their lead pipeline products. Additional programs are recruiting or preparing for IND submission.
- Therapeutic areas
- OncologyRare DiseasesImmunologyNeurology
- Modalities
- CAR-NK cell therapySingle-base gene editingiPSC (induced pluripotent stem cell) technology
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →03
Partnerships
Clinical collaborations with Shanghai Changhai Hospital and Affiliated Hospital of Jiangsu UniversityChangshu No. 2 People's Hospital as a trial site sponsor/collaborator
Beyond the preview
Go deeper on Rui Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rui Therapeutics.